Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Exploiting the fitness cost of carbapenem-resistance in Gram-negative bacteria

FY 2021-22

Summary
The current rise in multidrug-resistant bacteria is causing a growing health crisis, necessitating the urgent development of novel strategies to treat bacterial infections. Carbapenems are becoming an increasingly essential group of antibiotics in the treatment of multidrug-resistant bacteria. However, due to the substantial increase in use within the past two decades, resistance to carbapenems is rapidly spreading. As such, there is a critical need to develop new approaches to resensitize bacteria to carbapenem antibiotics. An intriguing strategy to overcome resistance is exploiting the fitness cost associated with antibiotic resistance. Evolved adaptions to antibiotics can alter metabolic pathways in the bacterium, imposing a fitness cost. These altered metabolic pathways are potential targets for combination therapies. Although the general impact of antibiotic resistance on bacterial physiology has been explored, the nutrient-poor environment that bacteria experience during clinical infection has not been accounted for. Preliminary work in the lab shows Escherichia coli expressing the carbapenem-resistance genes IMP-1 and VIM-2 have a growth defect in nutrient-limited media. The proposed project aims to identify the mechanism underlying the fitness cost of carbapenem resistance in biologically relevant growth conditions. We will leverage metabolite and genomic arrays to identify factors that either suppress or enhance the fitness cost. Rescued growth of carbapenem-resistant E. coli could inform on the mechanism of cost by highlighting metabolic pathways that regulate the growth defect. These pathways may represent an untapped target space for the design of innovative therapies that aim to restrict the spread of resistant pathogens.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
467090
Name
Tu Megan M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploiting the fitness cost of carbapenem-resistance in Gram-negative bacteria
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Bacterial Physiology; Carbapenems; Fitness Cost; Infectious Disease; Metabolism
Abstract
The current rise in multidrug-resistant bacteria is causing a growing health crisis, necessitating the urgent development of novel strategies to treat bacterial infections. Carbapenems are becoming an increasingly essential group of antibiotics in the treatment of multidrug-resistant bacteria. However, due to the substantial increase in use within the past two decades, resistance to carbapenems is rapidly spreading. As such, there is a critical need to develop new approaches to resensitize bacteria to carbapenem antibiotics. An intriguing strategy to overcome resistance is exploiting the fitness cost associated with antibiotic resistance. Evolved adaptions to antibiotics can alter metabolic pathways in the bacterium, imposing a fitness cost. These altered metabolic pathways are potential targets for combination therapies. Although the general impact of antibiotic resistance on bacterial physiology has been explored, the nutrient-poor environment that bacteria experience during clinical infection has not been accounted for. Preliminary work in the lab shows Escherichia coli expressing the carbapenem-resistance genes IMP-1 and VIM-2 have a growth defect in nutrient-limited media. The proposed project aims to identify the mechanism underlying the fitness cost of carbapenem resistance in biologically relevant growth conditions. We will leverage metabolite and genomic arrays to identify factors that either suppress or enhance the fitness cost. Rescued growth of carbapenem-resistant E. coli could inform on the mechanism of cost by highlighting metabolic pathways that regulate the growth defect. These pathways may represent an untapped target space for the design of innovative therapies that aim to restrict the spread of resistant pathogens.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tu, Megan M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~